Perinatal lethal type II osteogenesis imperfecta: a case report

Perinatal lethal type II osteogenesis imperfecta: a case report

Imene Dahmane Ayadi^1,&, Emira Ben Hamida¹, Rania Ben Rebeh¹, Sihem Chaouachi¹, Zahra Marrakchi¹

¹Department of Neonatology, Charles Nicolle Hospital, Tunis-El Manar University, Tunis, Tunisia

^&Corresponding author
Imene Dahmane Ayadi, Department of Neonatology, Charles Nicolle Hospital, Boulevard 9 April, 1006, Tunis, Tunisia

Osteogenesis imperfecta (OI) is a rare inherited bone disease caused by defects in type I collagen synthesis secondary to mutations in type I collagen genes. Its prevalence is about 6-7 per 100 000 individuals [1]. Pathogenesis is related to quantitative or qualitative abnormalities of type I collagen. It consists of a heterogeneous group of skeletal dysplasia characterized by clinical variability and genetic polymorphism. Generally, there is a correlation between the clinical features and genetic mutation. OI type II is the most severe form. It is a lethal form with collagen abnormalities resulting in dwarfism, bone fragility and deformity with in utero or perinatal death [2]. There are diagnosis difficulties between OI and other skeletal dysplasia. OI type II is a severe form with early fetal skeletal defects, thus early prenatal sonographic diagnosis is possible.

A term female neonate born vaginally to a 29-year-old mother. There was no consanguinity, no family history of OI. Pregnancy was uneventful, prenatal laboratory test results were within reference ranges. First trimester ultrasound didn't objectified abnormalities. Prenatal ultrasound examination at 22 weeks of gestation objectified short and incurved limbs, narrow chest, with hypomineralization and multiple fractures of ribs and long bones. Interruption of pregnancy was proposed but refused by parents. Parents felt that the diagnosis was late. At birth, the newborn presented immediate neonatal respiratory distress. Postnatal examination showed macrocephaly, narrow chest, curved and shortened limbs. Postnatal bone radiography showed anomalies as follows: chest: hypomineralization, narrow thorax, multiple beaded ribs (Figure 1); limbs: bone demineralization, diaphyses deformities with fractures and callus formation (Figure 2, Figure 3); skull: poor mineralization, wormian bones (Figure 4). Based on postnatal findings, the diagnosis of OI type IIA was made confidently. Death occurred on day 25 of life related to respiratory failure, secondary to pulmonary hypoplasia.

Osteogenesis imperfecta (OI), also known as "brittle-bone disease" is an inherited disorder of bone formation [1]. The manifestations of OI consist of skeletal abnormalities such as osteopenia, fractures, deformities, and joint laxity; associated with extraskeletal features, which are highly distinctive such as blue sclerae, dentinogenesis imperfecta, hearing loss, and blood vessel fragility [3]. The prevalence of OI is about 6-7 per 100 000 individuals [1]. Severity and age at onset vary widely, from severe forms that are fatal in the perinatal period to mild forms diagnosed much later in life. A classification system that was originally proposed by Sillence and colleagues based on disease severity and progression; type II is the most severe form with perinatal death [4]. In 1984, a radiological subclassification of type II was proposed with dwarfism, lethality and multiple congenital long bone fractures present in all types. The OI type IIA is characterized by broad ribs with multiple fractures, continuous beaded ribs, severe undermodeling of femur [2]. Hydrops fetalis can be seen in association with this subtype. As it was in the present case, severe forms of OI are frequently diagnosed prenatally, as a consequence of in utero ultrasound scanning. The main classical sonographic features of OI type II include diffuse hypomineralization of the skeleton, shortening and bowing of long bones, multiple fractures [5]. It may be deformability of the skull under the passage of the probe ultrasound. In our observation, parents refused pregnancy termination; they found that the diagnostic was late. In fact, early prenatal diagnosis of OI type II is possible. Authors reported early prenatal diagnosis of OI type II by first trimester transvaginal sonography with detection of shortened curved long bones, multiple fractures and hypoechogenicity of the skeleton [6]. It is important to recognize that it can be difficult to distinguish between severe OI and other lethal skeletal dysplasias such as camptomelic dysplasia or thanatotropic dysplasia. However, ultrasound is the primary tool for prenatal screening and diagnosis of skeletal dysplasias, but in many times a precise diagnosis cannot be made. Tow-dimensional ultrasound showed limits, three-dimensional ultrasound seems to be a useful complementary method, and may improve accuracy of the prenatal diagnosis of skeletal disorders. Prenatal three-dimensional computed tomography is efficient for the diagnosis of specific fetal skeletal dysplasia. It is especially effective in confirming or excluding bone fractures, recognizing wormian bones and for detailed evaluation of the fetal spine [5,7]. However, controversies remain about its use for prenatal diagnosis in terms of fetal radiation. Authors propose magnetic resonance imaging (MRI) for prenatal diagnosis of OI type II. MRI offer high soft tissue resolution needed to study the non-ossified fetal skeleton. In addition, it provides information about the severity of lung hypoplasia [8]. At birth, infants with OI type IIA have very short limbs curved and/or distorted (their legs are often in a frog-leg position), long bones fractures, small chest, and soft skull. The sclerae are usually blue or gray. Respiratory and swallowing problems are common. Macrocephaly may be present, microcephaly is rarely present. The radiologic features are characteristic and include absent or limited mineralization; flat vertebral bodies; very short, telescoped, broad femurs; beaded and often broad short ribs in "bamboo" [1].The outcome of type IIA is poor with death in the perinatal period. Lethal OI is frequently associated with severe respiratory insufficiency secondary to pulmonary hypoplasia [9], as it was seen in our observation. In severe forms of OI, the occurrence of an index case, invites to offer genetic counseling to parents. This pathology is secondary to mutations in type I collagen genes. Mutations lead to a defect affecting the non-mineral part of bone responsible of severe bone fragility and defective ossification. Genetic mutations are often autosomal dominant and generally located on COL1A1 or COL1A2 (80-90%), which encode for the chains of type I collagen, the major structural protein of bone. Recessively inherited OI results in many cases from homozygous or compound heterozygous mutations in CRTAP and LEPRE1 which encode for proteins involved in collagen biosynthesis. Genetic counseling can be difficult, because more than 100 different mutations have been identified in patients with OI and novel mutations are recently found [10]. New cases of OI type II occurs frequently secondary to private autosomal dominant mutations or parental mosaicism with more genetic counseling difficulties.

OI type II is a rare lethal pathology of the skeleton with severe abnormalities that may be identified by first trimester ultrasound. Lethality implies that early prenatal diagnosis is necessary to help parents making a decision relative to pregnancy termination.

The authors declare no competing interests.

All authors participated to the diagnosis and the follow up of the patient. All authors contributed to the writing of the paper and have read and approved the final manuscript.

Figure 1: chest: hypomineralization, narrow thorax, multiple beaded ribs

Figure 2: bone demineralization; femur, tibia and fibula deformities with fractures

Figure 3: bone demineralization; humerus deformity; radius and ulna fractures with callus formation

Figure 4: skull: poor mineralization, wormian bones

1. Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM. Classification of Osteogenesis Imperfecta revisited. Eur J Med Genet. 2010; 53(1):1-5. PubMed | Google Scholar


2. Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet. 1984; 17(2):407-23. PubMed | Google Scholar


3. Baujat G, Lebre AS, Cormier-Daire V, Le Merrer M. Osteogenesis imperfecta, diagnosis information (clinical and genetic classification). Arch Pediatr. 2008; 15(5):789-91. PubMed | Google Scholar


4. Sillence D. Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop Relat Res. 1981; 159:11-25. PubMed | Google Scholar


5. Ruano R, Molho M, Roume J, Ville Y. Prenatal diagnosis of fetal skeletal dysplasias by combining two-dimensional and three-dimensional ultrasound and intrauterine three-dimensional helical computer tomography. Ultrasound Obstet Gynecol. 2004; 24(2):134-40. PubMed | Google Scholar


6. Buisson O, Senat MV, Laurenceau N, Ville Y. Update on prenatal diagnosis of osteogenesis imperfecta type II : an index case report diagnosed by ultrasonography in the first trimester. J Gynecol Obstet Biol Reprod (Paris). 2002; 31(7):672-6. PubMed | Google Scholar


7. Ulla M, Aiello H, Cobos MP, Orioli I, García-Mónaco R, Etchegaray A, Igarzábal ML, Otaño L. Prenatal diagnosis of skeletal dysplasias: contribution of three-dimensional computed tomography. Fetal Diagn Ther. 2011; 29(3):238-47. PubMed | Google Scholar


8. Solopova A, Wisser J, Huisman TA. Osteogenesis imperfecta type II: fetal magnetic resonance imaging findings. Fetal Diagn Ther. 2008; 24(4):361-7. PubMed | Google Scholar


9. Shapiro JR, Burn VE, Chipman SD, Jacobs JB, Schloo B, Reid L, Larsen N, Louis F. Pulmonary hypoplasia and osteogenesis imperfecta type II with defective synthesis of alpha I(1)procollagen. Bone. 1989; 10(3):165-71. PubMed | Google Scholar


10. Wang Y, Cui Y, Zhou X, Han J. Development of a high-throughput resequencing array for the detection of pathogenicmutations in osteogenesis imperfecta. PLoS One. 2015; 10(3):e0119553. PubMed | Google Scholar